Incorrect Use of Isotype Controls for Gating Dim Markers
Symptom
Gates set using isotype controls for dim or activation markers result in inaccurate population identification, with either false negatives (missed positive cells) or false positives.
Common Causes
1Isotype controls measure only non-specific binding, not fluorescence spillover from other channels
2Dim activation markers (CD25, CD69, HLA-DR) have subtle signal differences that isotypes cannot accurately define
3Multicolor panels with spectral overlap require spillover-corrected gating strategies
4Isotype controls do not account for biological variability in low-expressing populations
Solutions
1Use FMO (Fluorescence Minus One) controls for all dim markers, activation markers, and multicolor panels to accurately define gating boundaries
2For spectral cytometry systems, always rely on FMO controls rather than isotype controls
3Reserve isotype controls for assessing overall background in high-background samples (myeloid cells, tumor cells), not for gating
4Establish gates using biological controls (unstimulated vs stimulated cells) when available
5Perform proper compensation and use single-stained controls to address spillover issues